Drugs@FDA record for NDA 020212 (ZINECARD, dexrazoxane hydrochloride) – original approval 26 May 1995 (1995)

Government Record · U.S. Food and Drug Administration, Center for Drug Evaluation and Research · May 26, 1995

U.S. Food et al., 1995-05-26: The FDA approval record for Zinecard shows dexrazoxane approved 26 May 1995 as a new molecular entity under priority and orphan review, with the brand now listed as discontinued but not withdrawn for safety or effectiveness reasons.

Type 1 – New Molecular Entity

'Approval Date(s) and History' table, ORIG-1 row (cell text)

U.S. Food et al., 1995-05-26: The FDA approval record for Zinecard shows dexrazoxane approved 26 May 1995 as a new molecular entity under priority and orphan review, with the brand now listed as discontinued but not withdrawn for safety or effectiveness reasons. Web-only database page: Drugs@FDA serves no PDF for this record, hence empty pdf_url. Page is undated; document_date is the original approval date the page records, which sits in the adjacent table cell and reads verbatim '05/26/1995' against the ORIG-1 approval row. Funder/COI not applicable; maker Pfizer. The linked 1995 review PDF (accessdata.fda.gov/drugsatfda_docs/nda/pre96/020212Orig1s000rev.pdf) was opened and is an image scan whose only text layer is a FOIA cover note, so no page-level quote was taken from it. Study type: regulatory record.